BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 26341722)

  • 1. Acquisition of Portal Venous Circulating Tumor Cells From Patients With Pancreaticobiliary Cancers by Endoscopic Ultrasound.
    Catenacci DV; Chapman CG; Xu P; Koons A; Konda VJ; Siddiqui UD; Waxman I
    Gastroenterology; 2015 Dec; 149(7):1794-1803.e4. PubMed ID: 26341722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of clinical relevance of examining K-ras, p16 and p53 mutations along with allelic losses at 9p and 18q in EUS-guided fine needle aspiration samples of patients with chronic pancreatitis and pancreatic cancer.
    Salek C; Benesova L; Zavoral M; Nosek V; Kasperova L; Ryska M; Strnad R; Traboulsi E; Minarik M
    World J Gastroenterol; 2007 Jul; 13(27):3714-20. PubMed ID: 17659731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portal-vein blood samples as a new diagnostic entity for pancreatic cancer.
    Chapman CG; Waxman I
    Expert Rev Gastroenterol Hepatol; 2016 Jun; 10(6):665-7. PubMed ID: 27077275
    [No Abstract]   [Full Text] [Related]  

  • 4. Endoscopic ultrasound acquired portal venous circulating tumor cells predict progression free survival and overall survival in patients with pancreaticobiliary cancers.
    Chapman CG; Ayoub F; Swei E; Llano EM; Li B; Siddiqui UD; Waxman I
    Pancreatology; 2020 Dec; 20(8):1747-1754. PubMed ID: 33082106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EUS-Guided Portal Venous Sampling of Circulating Tumor Cells.
    Chapman CG; Waxman I
    Curr Gastroenterol Rep; 2019 Dec; 21(12):68. PubMed ID: 31813055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Local Recurrence of Pancreatic Cancer by KRAS Mutation Analysis Using Washes from Endoscopic Ultrasound-Guided Fine-Needle Aspiration.
    Matsumoto K; Kato H; Nouso K; Ako S; Kinugasa H; Horiguchi S; Saragai Y; Takada S; Yabe S; Muro S; Uchida D; Tomoda T; Okada H
    Dig Dis Sci; 2020 Oct; 65(10):2907-2913. PubMed ID: 31897893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
    Reicher S; Boyar FZ; Albitar M; Sulcova V; Agersborg S; Nga V; Zhou Y; Li G; Venegas R; French SW; Chung DS; Stabile BE; Eysselein VE; Anguiano A
    Pancreas; 2011 Oct; 40(7):1057-62. PubMed ID: 21705950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A High Circulating Tumor Cell Count in Portal Vein Predicts Liver Metastasis From Periampullary or Pancreatic Cancer: A High Portal Venous CTC Count Predicts Liver Metastases.
    Tien YW; Kuo HC; Ho BI; Chang MC; Chang YT; Cheng MF; Chen HL; Liang TY; Wang CF; Huang CY; Shew JY; Chang YC; Lee EY; Lee WH
    Medicine (Baltimore); 2016 Apr; 95(16):e3407. PubMed ID: 27100430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enumeration and targeted analysis of KRAS, BRAF and PIK3CA mutations in CTCs captured by a label-free platform: Comparison to ctDNA and tissue in metastatic colorectal cancer.
    Kidess-Sigal E; Liu HE; Triboulet MM; Che J; Ramani VC; Visser BC; Poultsides GA; Longacre TA; Marziali A; Vysotskaia V; Wiggin M; Heirich K; Hanft V; Keilholz U; Tinhofer I; Norton JA; Lee M; Sollier-Christen E; Jeffrey SS
    Oncotarget; 2016 Dec; 7(51):85349-85364. PubMed ID: 27863403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer.
    Zhang Y; Su H; Wang H; Xu C; Zhou S; Zhao J; Shen S; Xu G; Wang L; Zou X; Zhang S; Lv Y
    Cancer Manag Res; 2021; 13():7649-7661. PubMed ID: 34675662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Portal Venous Blood Circulation Supports Immunosuppressive Environment and Pancreatic Cancer Circulating Tumor Cell Activation.
    Arnoletti JP; Zhu X; Almodovar AJ; Veldhuis PP; Sause R; Griffith E; Corpus G; Chang JC; Fanaian N; Litherland SA
    Pancreas; 2017 Jan; 46(1):116-123. PubMed ID: 27400259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endoscopic ultrasound.
    Khara HS; Gross SA
    Endoscopy; 2014 Sep; 46(9):779-82. PubMed ID: 25133477
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of CA19.9, circulating tumour DNA and circulating tumour cells in patients with solid pancreatic tumours.
    Sefrioui D; Blanchard F; Toure E; Basile P; Beaussire L; Dolfus C; Perdrix A; Paresy M; Antonietti M; Iwanicki-Caron I; Alhameedi R; Lecleire S; Gangloff A; Schwarz L; Clatot F; Tuech JJ; Frébourg T; Jardin F; Sabourin JC; Sarafan-Vasseur N; Michel P; Di Fiore F
    Br J Cancer; 2017 Sep; 117(7):1017-1025. PubMed ID: 28772284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating tumor cells (Ctc) and kras mutant circulating free Dna (cfdna) detection in peripheral blood as biomarkers in patients diagnosed with exocrine pancreatic cancer.
    Earl J; Garcia-Nieto S; Martinez-Avila JC; Montans J; Sanjuanbenito A; Rodríguez-Garrote M; Lisa E; Mendía E; Lobo E; Malats N; Carrato A; Guillen-Ponce C
    BMC Cancer; 2015 Oct; 15():797. PubMed ID: 26498594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usefulness of rapid on-site evaluation specimens from endoscopic ultrasound-guided fine-needle aspiration for cancer gene panel testing: A retrospective study.
    Ishizawa T; Makino N; Matsuda A; Kakizaki Y; Kobayashi T; Ikeda C; Sugahara S; Tsunoda M; Ueno Y
    PLoS One; 2020; 15(1):e0228565. PubMed ID: 31999789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic circulating tumor cell detection by targeted single-cell next-generation sequencing.
    Yu J; Gemenetzis G; Kinny-Köster B; Habib JR; Groot VP; Teinor J; Yin L; Pu N; Hasanain A; van Oosten F; Javed AA; Weiss MJ; Burkhart RA; Burns WR; Goggins M; He J; Wolfgang CL
    Cancer Lett; 2020 Nov; 493():245-253. PubMed ID: 32896616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating Tumor Cell Phenotype Predicts Recurrence and Survival in Pancreatic Adenocarcinoma.
    Poruk KE; Valero V; Saunders T; Blackford AL; Griffin JF; Poling J; Hruban RH; Anders RA; Herman J; Zheng L; Rasheed ZA; Laheru DA; Ahuja N; Weiss MJ; Cameron JL; Goggins M; Iacobuzio-Donahue CA; Wood LD; Wolfgang CL
    Ann Surg; 2016 Dec; 264(6):1073-1081. PubMed ID: 26756760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Negative enrichment by immunomagnetic nanobeads for unbiased characterization of circulating tumor cells from peripheral blood of cancer patients.
    Liu Z; Fusi A; Klopocki E; Schmittel A; Tinhofer I; Nonnenmacher A; Keilholz U
    J Transl Med; 2011 May; 9():70. PubMed ID: 21595914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Portal vein-circulating tumor cells predict liver metastases in patients with resectable pancreatic cancer.
    Bissolati M; Sandri MT; Burtulo G; Zorzino L; Balzano G; Braga M
    Tumour Biol; 2015 Feb; 36(2):991-6. PubMed ID: 25318603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted next generation sequencing of endoscopic ultrasound acquired cytology from ampullary and pancreatic adenocarcinoma has the potential to aid patient stratification for optimal therapy selection.
    Gleeson FC; Kerr SE; Kipp BR; Voss JS; Minot DM; Tu ZJ; Henry MR; Graham RP; Vasmatzis G; Cheville JC; Lazaridis KN; Levy MJ
    Oncotarget; 2016 Aug; 7(34):54526-54536. PubMed ID: 27203738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.